Neudle.com: dopaminergic neurons

Differential
(Click to cross reference)

acetylcholine

acrochordon

acromegaly

activities of daily living

Addison's disease

advances in neurology

adverse drug reaction

alcohol, neurologic complications with

alcoholism

alopecia

alpha methyldopa hydrazine

alpha methyltyrosine

alpha-synuclein

altered states of consciousness, driving with

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, etiology of

anasarca

anemia, iron deficiency

angiography, cerebral

ankle edema

anticholinergic drugs

anticholinergic drugs, side effects of

anticonvulsants

anxiety

aortic valve, lesion of

aphasia

aphasia, rehabilitation

apomorphine

arrhythmia, cardiac

arterial dissection, aorta, cerebral symptoms with

arteriopathy

ataxia, truncal

attention deficit disorder with hyperactivity

atypical

automobile accidents

autonomic dysfunction

basal ganglia, lesion of

behavioral disorder

benzodiazepine

beta adrenergic blocker

bitemporal visual field defect

brain implant, polymeric

brain transplantation

bromocriptine

bromocriptine, slow release

carpal tunnel syndrome

CAT scan, emission, abnormal

catecholamine

catechol-o-methyltransferase inhibitor

cerebellar pontine angle

cerebellar pontine angle tumor

cerebral ischemia

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, leak

cerebrovascular accident

cerebrovascular accident, women

chest x-ray, abnormal

Chiari Frommel syndrome

chromophobe adenoma, treatment of

chromosomal abnormality

cirrhosis

cisternogram, radionuclide

congestive heart failure

conjunctival injection

constipation

controversies in neurology

coronary artery disease

cough

cranial nerve palsies

degenerative diseases of CNS

dexamethasone suppression test

disability rating scale, neurological

disability, neurological

diurnal variation

domperidone

dopa responsive dystonia

dopamine

dopamine agonist

dopamine agonist withdrawal syndrome

dopamine antagonist

dopamine antagonist, peripheral

dopamine receptor

dopamine receptor, D2

dopaminergic desensitization

dopaminergic dysfunction

dopaminergic neurons

doppler, transcranial

downward gaze, paralysis of

driving

drug induced neurologic disorders

dystonia musculorum deformens

dystonia, face

dystonia, focal

echocardiogram

echocardiogram, transthoracic

edema, pedal

efficacy

electroconvulsive therapy

emergencies, neurologic

epidemiology of neurology

eye movement, disorders of

fine motor function, impaired

flushing

follicle stimulating hormone

gamma amino butyric acid

gastrointestinal bleeding

gaze palsy, horizontal

gaze palsy, vertical

gene

gene mutation

genetic neurologic disorders

Gilles de la Tourette syndrome

glabellar sign

glomus jugulare tumor

goiter

growth hormone

growth hormone deficiency

hair, loss

hallucination

hallucination, auditory

haloperidol

handwriting

headache

headache, drug induced

headache, treatment of

hearing loss

hemidystonia

hepatic encephalopathy

hepatic encephalopathy, treatment of

heralding manifestation

hypotension, systemic

hypothalamus, damage to

hypothermia

hypothyroidism

iatrogenic neurologic disorders

internuclear ophthalmoplegia

intracerebral hemorrhage

L-dopa, controlled release

L-dopa, drug interactions with and side effects of

L-dopa, potentiators of

lergotrile

Lesch-Nyhan syndrome

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

locus ceruleus, lesion of

medication withdrawal

microsurgery, transsphenoidal

migraine

migraine, menses

migraine, treatment of

misdiagnosis

mitochondrial disease

mitral valve lesion

mitral valve regurgitation

molecular genetics

monoamine oxidase inhibitors

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, extrapyramidal-treatment of

movement disorder, treatment of

MPTP

MRI

MRI, abnormal

MRI, contrast enhanced

neoplasm, hormone producing

neoplasm, hormone producing, ectopic

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS-treatment of

neoplasm, pituitary

neoplasm, pituitary, incidental

neoplasm, pituitary, treatment of

neoplasm, primary of CNS-metastasizing to subarachnoid space

neoplasm, primary of CNS-treatment of

neurochemistry

neuroendocrinology

neuroleptic

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications of, surgery

neurologic disease, diagnoses of

neurologic signs

neurologic symptoms

neurologic testing

neuronal degeneration

neurons

neuropathology

neuropathology, brain

neuropathy

neuroprotective agents

neurotoxic

neurotransmitter

nigrostriatal pathway

norepinephrine

obsessive-compulsive disorder

optic chiasm, herniation

oral contraceptives

oral contraceptives, neurologic complications with

orthostatic hypotension

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, driving with

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

parsidol

pathologic gambling

pathology

patient information and support

PHNO, enteral infusion, continuous

pituitary, adenoma, giant

pituitary, enlargement

pituitary, hormones of

pituitary, lesion of

pituitary, microadenoma

polyps, gastrointestinal tract

polysomnogram

postpartum

postpartum cerebral angiopathy

practice guidelines

pramipexole

pramipexole, extended release

pregabalin

pregnancy, neurologic complications in

PRKN gene

procyclidine

prognosis

progressive supranuclear palsy

psychiatric problems in neurologic disorders

psychological testing

psychological testing, neurologic problems

radiation therapy, CNS treatment and complications with

radiation therapy, stereotactic

radioimmunoassay

radiotracer imaging

raphe nuclei

reserpine and reserpine like drugs

respiratory failure

restless arms syndrome

restless genital syndrome

restless leg syndrome

retroperitoneal fibrosis

risk-benefit assessment

ritalin

ropinirole

ropinirole, prolonged release

rotigotine

safety

seizure

sella turcica, enlargement of

sensorineural hearing loss

single photon emission computed tomography

skin, lesions in neurologic disorders

skull x-ray

skull x-ray, abnormal

sleep

sleep apnea

sleep pathology and physiology

smell

Smell Identification Test

somatostatin analogue

stem cell transplantation

stereotyped behavior

stereotyped behavior, drug induced

stereotypy

stimulation, deep brain

striatum, lesion of

subclavian steal syndrome, causes of

substantia nigra

subthalamic nucleus

subthalamic nucleus deep brain stimulation

tardive dyskinesia, treatment of

testicular atrophy

testosterone, serum

testosterone, serum, low

transdermal medication

trauma

treatment of neurologic disorder

tremor

tremor, resting

tremor, thalamic stimulation for suppression of

tricuspid valve, lesion of

tricyclic antidepressant

trismus

twins

undiagnosed

Unified Parkinson Rating Scale

visual acuity, decreased

Showing articles 150 to 200 of 236 << Previous Next >>

Bromocriptine Induced Impotence in Parkinson's Disease
BMJ 295:367-368, Cleves,L., 1987

Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986

Low-Dose Bromocriptine Therapy in Parkinson's Disease:Double-Blind, Placebo-Controlled Study
Neurol 36:291-293, Staal-Schreinemachers,A.L.,et al, 1986

Placebo-Controlled Study of Mesulergine in Parkinson's Disease
Neurol 35:161-165, Jankovic,J.,et al, 1985

Hyperthermia after Discontinuance of Levodopa & Bromocriptine Therapy:Impaired Dopamine Receptors a Possible Cause
Neurol 35:258-261, Figa-Talamanca,L.,et al, 1985

Low Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas
NEJM 313:656-659, Liuzzi,A.,et al, 1985

Cerebrospinal Fluid Rhinorrhea During Treatment with Bromocriptine for Prolactinoma
Neurol 35:1193-1195, Kok,J.G.,et al, 1985

Low-Dose Bromocriptine Therapy in Parkinson's Disease
Arch Neurol 42:586-588, Pfeiffer,R.F.,et al, 1985

Mesulergin (CU32-085) in the Treatment of Parkinson's Disease
Ann Neurol 17:334-336, Pfeiffer,R.F.,et al, 1985

Neuroleptic Malignant Syndrome
NEJM 313:163-166, Guze,B.H.,et al, 1985

Prolactinomas
Editorial, BMJ 290:182-1841985., Grossman,A.,et al, 1985

Low Dosages of Bromocriptine Added to Levodopa in Parkinson's Disease
Neurol 35:199-206, Maier,M.M.,et al, 1985

Long-Term Study of Pergolide in Parkinson's Disease
Neurol 35:296-299, Jankovic,J., 1985

Pergolide in the Treatment of Parkinson's Disease
Neurol 34:983-986, Mear,J.,et al, 1984

Rapid Size Reduction of Giant Prolactinoma Following Medical Treatment
J Comput Assist Tomogr 8:131-133, Perani,D.,et al, 1984

Cerebrospinal Fluid Rhinorrhea Caused by Bromocriptine Therapy of Prolactinoma
Neurol 34:111-113, Holness,R.O.,et al, 1984

Treatment of Prolactinomas with Megavoltage Radiotherapy
BMJ 288:1105-1109, Grossman,A.,et al, 1984

Neuroleptic Malignant Syndrome
Lancet 1:545-546, Smego,R.A.,et al, 1984

Psychotic Reactions During Treatment of Pituitary Tumours with Dopamine Agonists
BMJ 289:1101-1103, Turner,T.H.,et al, 1984

Effect of Dopamine Agonist Withdrawal After Long-Term Therapy in Prolactinomas
Lancet 2:187-192, Johnston,D.G.,et al, 1984

Pergolide in Parkinson's Disease
Arch Neurol 40:785-787, Goetz,C.G.,et al, 1983

Hyperprolactinemia
Am J Med 75:868-874, Johnston,D.G.,et al, 1983

Urinary Incontinence in Patient on Long-Term Bromocriptine
Lancet 2:1260-1261, Sandyk,R.,et al, 1983

Progressive Supranuclear Palsy:Clinical Features & Response to Treatment in 16 Patients
Ann Neurol 13:273-278, Jackson,J.A.,et al, 1983

Failure of Bromocriptine to Maintain Reduction in Size of a Macroprolactinoma
BMJ 287:451-452, Breidahl,H.D.,et al, 1983

Treatment of Acromegaly
BMJ 286:330-332, Thomas,J.P., 1983

Bromocriptine & Lisuride in Parkinson Disease
Ann Neurol 13:44-47, Lieberman,A.N.,et al, 1983

Comparison of Pergolide & Bromocriptine Therapy in Parkinsonism
Neurol 33:1009-1014, LeWitt,P.A.,et al, 1983

Neuroleptic Malignant Syndrome:Successful Treatment with Dantolene & Bromocriptine
Ann Neurol 14:89-90, Granato,J.E.,et al, 1983

Neuroleptic Malignant Syndrome, Successful Treatment with Bromocriptine
JAMA 249:386-388, Mueller,P.S.,et al, 1983

Bromocriptine Reduces Pituitary Tumor Size & Hyper-secretion
JAMA 247:311-316, Spark,R.F.,et al, 1982

CSF Rhinorrhea After Bromocriptine For Prolactinoma
NEJM 306:178, Baskin,D.S.,et al, 1982

Lisuride Versus Bromocriptine Treatment in Parkinson Disease:A Double-blind Study
Neurol 32:69-72, LeWitt,P.A.,et al, 1982

Bromocriptine in Management of Large Pituitary Tumours
BMJ 284:1908-1911, Wass,J.A.H.,et al, 1982

Size Reduction of Extrasellar Pituitary Tumors During Bromocriptine Treatment
Ann Int Med 96:281-286, Wollesen,F.,et al, 1982

Reduction in Size of Prolactin-secreting Tumours in Men Treated with Pergolide
BMJ 285:465-467, Kendall-Taylor,P.,et al, 1982

Bromocriptine-induced psychosis in acromegaly
BMJ 285:1315, Lefeuvre,C.M.,et al, 1982

Bromocriptine:Low-dose Therapy in Parkinson Disease
Neurol 32:577-583, Teychenne,P.F.,et al, 1982

Pergolide Mesylate & Idiopathic Parkinson Disease
Neurol 32:1175-1179, Tanner,C.M.,et al, 1982

Pergolide in Late-Stage Parkinson Disease
Ann Neurol 12:243-247, Lang,A.E.,et al, 1982

Further Studies with Pergolide in Parkinson Disease
Neurol 32:1181-1184, Lieberman,A.N.,et al, 1982

Prolactinoma:A Question of Rational Treatment
BMJ 283:1561-1562, Edwards,C.R.W.,et al, 1981

Bromocriptine Therapy for"Nonfunctioning"Pituitary Tumors
Am J Med 71:1059-1061, Johnston,D.G.,et al, 1981

Bromocriptine In Acromegaly
NEJM 305:1092-1093, Thorner,M.O.,et al, 1981

Effect Of Bromocriptine On Brain Metastasis In Breast Cancer
Lancet 2:745-746, Grisoli,F.,et al, 1981

Lisuride in Parkinson Disease:Efficacy of Lisuride Compared to Levodopa
Neurol 31:961-965, Lieberman,A.N.,et al, 1981

No Effect Of Bromocriptine In Acromegaly
NEJM 304:1450-1454, Lindholm,J.,et al, 1981

Regression of Pituitary Prolactinoma With Bromocriptine Administration
JAMA 245:1149-1150, Velentzas,C.,et al, 1981

Mental Disorders From Low-Dose Bromocriptine
NEJM 305:173, Pearson,K.D., 1981

Bromocriptine & Domperidone in the Treatment of Parkinson Disease
Neurol 31:662-667, Quinn,N.,et al, 1981

Showing articles 150 to 200 of 236 << Previous Next >>